IDH1 and central nervous system cancer: The skewed distribution of IDH1 genotypes have been acknowledged in literature; studies with low grade gliomas involved predominantly IDH1 mutants [33,37] and studies with glioblastomas involved predominantly IDH1 wildtypes [10,28].